ClinConnect ClinConnect Logo
Search / Trial NCT06626347

Telemedicine for Reach, Education, Access, and Treatment for Diabetes Self-Management Education and Support

Launched by UNIVERSITY OF PITTSBURGH · Oct 1, 2024

Trial Information

Current as of August 28, 2025

Enrolling by invitation

Keywords

Type 1 Diabetes Emerging Adults Telemedicine Health Care Delivery Diabetes Self Management Education And Support Visit Attendance

ClinConnect Summary

Diabetes self-management education and support is considered a cornerstone of care and essential in helping people navigate self-management decisions and activities. Despite evidence that diabetes self-management education and support is a critical component of diabetes care, participation remains low. Emerging adulthood has been described as the distinct period between 18 and 25 years when adolescents work to achieve autonomy and explore life possibilities in moving toward adulthood. Suboptimal self-management has been identified as a major problem in emerging adults with type 1 diabetes, ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosed with type 1 diabetes (ICD10 E10.xx, O24.0x)
  • 18 to 25 years of age at time of study enrollment
  • Able to communicate via videoconferencing platform
  • Intending to maintain status as a patient at participating clinical sites throughout the study duration
  • Able to provide informed consent
  • Exclusion Criteria:
  • Do not have a diagnosis of type 1 diabetes (ICD10 E10.xx, O24.0x)
  • Less than 18 or older than 25 years old at time of enrollment
  • Do not intend to maintain their care at participating clinical sites throughout the duration of the study
  • Are unable to communicate via telemedicine
  • Has other concerns that may interfere significantly with their ability to participate in the intervention (ongoing health issues, personal events, etc.)

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Ingrid Libman, MD, PhD

Principal Investigator

University of Pittsburgh

Linda Siminerio, RN, PhD, CDCES

Principal Investigator

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported